Relief offered in underserved areas. The Health Care Group.
Explore the source record for details and available documents.
SEARCH · PubMed Health
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The health care system in the United States depends on primary care services. Yet the limitations imposed by traditional approaches in primary care have resulted in an unrealized potential for primary care. Currently, we rely on the motivation and initiative of persons to acquire the health care services they need, and health care providers have attempted to meet these needs. Community-oriented primary care provides an opportunity for primary care physicians to expand their range of services and their ability to reach out to people. Incorporating community-oriented primary care into primary health care has the potential to make a major contribution in reshaping health care in the United States.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Reimbursement policies for health-care services in Connecticut and the U.S. have gradually shifted towards fixed reimbursements through implementation of managed care. As a result, there is an increasing need by physicians and other care givers to reduce costs without compromising the quality of the care being delivered. The clinical laboratory is one area where significant cost reductions may be realized. More effective utilization can be accomplished with the elimination of panels of tests, such as the general chemistry profile, removal of antiquated tests or those that provide redundant information, judicious use of drug assays, acceptance of clinical practice guidelines, and use of reflex testing algorithms. Physicians should also focus more on prognostic indicators for disease prevention. Point-of-care testing devices which have higher costs than incremental central laboratory expenses should be used only if it reduces overall operating expenses, as assessed by outcomes analyses. New technologies such as DNA probes can substantially improve diagnostic efficiency. Physicians and clinical laboratories must collaborate to achieve more efficient utilization practices.
OBJECTIVE: To assess the effects of an alternative method of paying home health agencies for services to Medicare beneficiaries, based on a demonstration program. DATA SOURCES/STUDY SETTING: Primary and secondary data collected on participating home health agencies in five states and their patients during the three-year demonstration period. Primary data included patient surveys at discharge and six months later, and two rounds of interviews with executive staff of the agencies. Secondary data included agencies' Medicare cost reports, quality assurance reviews, Medicare claims data, demonstration claims data, demonstration patient intake forms, and plan of treatment forms. STUDY DESIGN: The 47 agencies volunteering to participate in the demonstration were each randomly assigned to the treatment or control group. Treatment group agencies were paid a predetermined rate based on their inflation-adjusted cost per visit during the year preceding the demonstration; control group agencies were paid under Medicare's conventional cost reimbursement method. Demonstration impacts were estimated by comparing outcomes for the two groups of agencies and their respective patients, using regression models to control for any remaining differences. PRINCIPAL FINDINGS: Agencies paid under prospective rate setting were slightly better at holding per-visit cost increases below inflation than were control group agencies. The change in payment method had no effect on agencies' volume of Medicare visits or quality of care, nor on patients' use of Medicare services or other formal or informal care services. CONCLUSION: Changing from cost-based reimbursement to predetermined payment rates for Medicare home healthcare visits would not lead to large savings for the Medicare program, but would not increase costs to Medicare or adversely affect patients or their caregivers.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
As they attempt to increase health insurance coverage and improve the efficiency of the market, researchers, policymakers, and health plan representatives have been addressing the issue of risk segmentation. Many risk assessment tools and risk-adjusted payment methodologies have been developed and demonstrated for a variety of populations and payers experiencing various market constraints. The evidence shows that risk-adjusted payments are feasible for most populations receiving acute care, while technical obstacles, political issues, and some research gaps remain.
The key question addressed in this study is whether performance-based reimbursement (PBR) is a useful way to create the right incentive for efficiency improvements in health care. In this 4-year prospective cohort study, physicians in one council with PBR and in ten councils without such a system were studied. The results of this study indicate that PBR, compared to an annual budget system, creates a different incentive, an 'inner incentive' which may be stronger than the external incentive of financial pressures. PBR may result in a greater cost awareness and shorter average length of stay, but it may also lead to negative effects on the quality of care. A strong cost awareness was found to be a negative predictor of quality of care indicating that it is a difficult balancing act to maintain cost considerations at a 'good' level in order to retain the benefits of cost awareness without adversely impacting quality of care. There is a need for further studies of the impact of PBR on financial performance and quality of care issues.
Historically, cost-based reimbursement encouraged hospitals to compete on the basis of quality, leading to duplication of services and other inefficient behavior. More recently, prospective payment, selective contracting, and other innovations in reimbursement have strengthened incentives for more efficient hospital operations. In principle, hospitals may be able to reduce their costs by limiting the array of services they provide, but there has been little empirical evidence that U.S. hospitals are moving toward greater specialization or that specialization leads to cost savings. This article explores recent changes in case-mix specialization and the relationship of these changes to hospital costs. It first describes an index of specialization derived from Information Theory and shows that this index provides intuitively reasonable results in characterizing patterns of specialization across hospitals. The analysis then demonstrates that specialization, as measured by this index, in fact increased from 1980 through 1985; that specialization can indeed lower hospital costs; and that increases in specialization have been largest in those hospitals with the greatest incentives to reduce costs.
Although proposed Medicare reimbursement changes may reduce financial incentives to develop specialty hospitals, other anticipated reimbursement changes, such as pay for performance, could perpetuate current growth trends. Hospital executives will need to develop new tools for coping with the continued development of specialty hospitals.
Current reimbursement mechanisms provide incentives for health systems to develop or have access to and utilize a variety of postacute care settings, but not necessarily to provide integrated care across those settings. While most health care systems speak of providing integrated care, few actually do. Several market forces are now making health systems reexamine how care is provided across the continuum and creating the incentives for health systems to integrate care across each level within the continuum. This article describes how to develop integrated levels of care and the strategic implications of doing so.
The goal of capitation is to place gatekeepers at financial risk for the services the deliver. However, third party payers should provide gatekeepers with some type of protection against random and systematic risk transfer. Gatekeeper physicians' other alternative is to reduce this risk on their own by actively marketing services to healthier individuals and creating barriers to care for their sicker patients. Thus, the proper balance of risk transfer will result in the most cost-efficient, quality gatekeeper networks. However, even with the right balance of risk transfer, capitation may provide incentive for some physicians to withhold necessary services to further increase their profit margins-making quality of care a key concern. Thus, practice guidelines should be developed to ensure quality is not affected. These guidelines afford explicit criteria on how gatekeepers should respond in specific clinical situations.